“…Although such in‐vitro cascade allows the highest flexibility to balance enzyme ratios for enhancing reaction performance (Muschiol et al, ), the necessity of several unit operations for the production of isolated enzymes and cofactors leads to high CapEx and OpEx costs. In this context, in‐vivo cascade offers economic perspectives by combining production and regeneration of enzymes and cofactors necessary to conduct cascade reactions in one single unit operation (Bayer, Milker, Wiesinger, Rudroff, & Mihovilovic, ; de Carvalho, ; Schrewe, Julsing, Bühler, & Schmid, ; Schrittwieser et al, ). However, for the efficient turnover of the in‐vivo cascade, the catalytic efficiency of the individual enzymes needs to be compatible to streamline substrate conversion toward the main product without accumulation of intermediate compounds.…”